Mr. Chair, I'll highlight several dimensions.
One of them, as noted, is that we have over the past number of years built our internal capacity for forecasting and understanding supply and demand; early identification of potential risks and shortages; and changing our regulatory instruments to enable foreign importation. In addition, we have been working with regulatory partners to strengthen the diversification of supply chains.
Then, finally and importantly, the government has invested two and a half billion dollars to strengthen domestic biomanufacturing, both—